🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Northwest Biotherapeutics, Inc. (NWBO)
OTCMKTS · Delayed Price · Currency is USD
0.1265
-0.0125 (-8.99%)
At close: Nov 20, 2026

Northwest Biotherapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
226358364822830663
Market Cap Growth
-39.96%-1.53%-55.72%-1.00%25.14%-47.13%
Enterprise Value
305444435881865686
Last Close Price
0.130.230.270.700.780.70

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-----3.70
PS Ratio
79.03260.08263.35425.38493.23660.04
PB Ratio
--7.53-4.61-17.47-7.90-5.35

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
106.87322.41314.92455.93513.96682.10

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-1.51-1.36-0.85-0.97-0.25-0.31
Net Debt / Equity Ratio
-1.49-1.30-0.83-0.92-0.18-0.18
Net Debt / EBITDA Ratio
-1.61-1.07-1.01-0.80-0.29-0.43
Net Debt / FCF Ratio
-1.55-1.33-1.12-0.76-0.35-0.51
Asset Turnover
0.050.030.050.070.050.03
Quick Ratio
0.010.030.030.050.060.11
Current Ratio
0.030.060.060.090.080.13
Return on Assets (ROA)
-76.28%-113.83%-312.10%-217.52%-293.87%490.36%
Return on Capital Employed (ROCE)
310.50%575.50%160.10%320.10%71.00%56.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-24.63%-16.79%-23.02%-7.62%-12.65%27.00%
FCF Yield
-19.71%-12.91%-15.95%-6.94%-6.71%-6.68%
Buyback Yield / Dilution
-15.65%-17.26%-10.99%-10.17%-0.79%-38.99%